Viatris has faced volatility since its 2020 formation but is now in Phase 2 of its transformation. Learn why VTRS stock could ...

Syngene International slumped 6.17% to Rs 795 after the company projected single-digit revenue growth and flat profit after tax (PAT) for the full year, with unchanged EBITDA guidance.

Critical pain points need to be overcome for the animal healthcare industry to achieve its full potential.

Pune: While speaking on 67 cases of Guillain-Barre Syndrome (GBS) reported in Pune district, Assistant Health Officer, Pune Municipal Corporation Vaishali Jadhav said that a total of 67 cases of ...

Syngene International revised its revenue expectations due to further delays in the US biotech funding environment during the third quarter.

The Finance Minister is expected to prioritise economic growth, domestic manufacturing, and offer relief to consumers in the upcoming budget to address inflation, fiscal consolidation, and job creatio ...